Walgreen Company (WAG) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts WAG Hot Sheet
Price: $76.05 --0%
Financial Fact:
Net earnings per common share - basic: 0.86
Today's EPS Names:
PLCE, COE, JVA, More
Financial Fact:
Net earnings per common share - basic: 0.86
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Walgreen Company (NYSE: WAG) reported Q1 EPS of $0.72, in-line with the analyst estimate of $0.72. Revenue for the quarter came in at $18.3 billion versus the consensus estimate of $17.98 billion.
Front-end comparable store sales (those open at least a year) increased 2.4 percent in the first quarter, customer traffic in comparable stores increased 0.2 percent and basket size increased 2.2 percent, while total sales in comparable stores increased 5.4 percent.
Prescription sales, which accounted for 64.7 percent of sales in the quarter, increased 7.3 percent, while prescription sales in comparable stores increased 7.2 percent. The company filled a record 213 million prescriptions in the quarter, an increase of 5.8 percent over last year’s first quarter. Prescriptions filled in comparable stores increased 5.5 percent in the quarter. The company exceeded by 2.9 percentage points the prescription growth rate of the rest of the industry during the same period as reported by IMS Health. As of Nov. 30, Walgreens increased its retail prescription market share 50 basis points from a year ago to 19.4 percent, also as reported by IMS Health on a 30-day adjusted basis.
For earnings history and earnings-related data on Walgreen Company (WAG) click here.
Front-end comparable store sales (those open at least a year) increased 2.4 percent in the first quarter, customer traffic in comparable stores increased 0.2 percent and basket size increased 2.2 percent, while total sales in comparable stores increased 5.4 percent.
Prescription sales, which accounted for 64.7 percent of sales in the quarter, increased 7.3 percent, while prescription sales in comparable stores increased 7.2 percent. The company filled a record 213 million prescriptions in the quarter, an increase of 5.8 percent over last year’s first quarter. Prescriptions filled in comparable stores increased 5.5 percent in the quarter. The company exceeded by 2.9 percentage points the prescription growth rate of the rest of the industry during the same period as reported by IMS Health. As of Nov. 30, Walgreens increased its retail prescription market share 50 basis points from a year ago to 19.4 percent, also as reported by IMS Health on a 30-day adjusted basis.
For earnings history and earnings-related data on Walgreen Company (WAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
Create E-mail Alert Related Categories
Earnings, Hot Earnings, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
